Understand the source comparison
Peptides for Gut Health Research: Mechanism Comparison
The table below compares commonly studied peptides for gut health research based on their primary mechanism of action, documented research applications, and key study endpoints. This comparison helps researchers select compounds aligned with their experimental
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The table below compares commonly studied peptides for gut health research based on their primary mechanism of action, documented research applications, and key study endpoints. This comparison helps researchers select compounds aligned with their experimental design.
- BPC-157
- Growth factor signaling (VEGF, FGF); angiogenesis promotion
- Mucosal healing, ulcer repair, anastomotic healing, colitis models
- Histological damage scores, occludin/claudin expression, myeloperoxidase activity, VEGF mRNA levels
- Most extensively studied for structural tissue repair; consistent preclinical data but limited Phase III human trials
- KPV (Lys-Pro-Val)
- NF-kB inhibition; anti-inflammatory cytokine modulation
- Inflammatory bowel disease models, colitis, systemic inflammation
- IL-6, TNF-alpha, histological inflammation scores, NF-kB translocation assays
- Potent anti-inflammatory with oral bioavailability; derived from endogenous alpha-MSH
- Thymosin Alpha 1
- T-cell maturation; Th1/Th2 cytokine balance
- Immune modulation in IBD, chronic hepatitis, post-surgical recovery
- Fecal calprotectin, serum cytokines, T-cell subset analysis, quality-of-life scores
- Immunomodulatory rather than directly gut-targeted; affects systemic immune tone
- LL-37
- Antimicrobial peptide; bacterial membrane disruption
- SIBO, pathogenic bacterial overgrowth, microbiome modulation
- MIC assays, 16S microbiome sequencing, bacterial adhesion, mucosal immune markers
- Only human cathelicidin; selective antimicrobial activity with immune-regulatory effects
- TB-500 (Thymosin Beta-4)
- Actin sequestration; cell migration and differentiation
- Wound healing, epithelial regeneration, fibrosis reduction
- Epithelial continuity, Ki-67 proliferation markers, collagen deposition, angiogenesis
- Promotes cell migration and reduces fibrosis; studied in cardiac and musculoskeletal models with emerging GI applications
- VIP (Vasoactive Intestinal Peptide)
- cAMP signaling; smooth muscle relaxation; anti-inflammatory
- Motility disorders, colitis, immune modulation
- Intestinal transit time, cytokine profiles, smooth muscle contractility, histology
- Neuropeptide with pleiotropic effects; dose-dependent vasodilation can limit systemic use